Company Filing History:
Years Active: 2017
Title: Stéphane Mornet: Innovator in Ferrofluid Technology
Introduction
Stéphane Mornet is a notable inventor based in Artigues Pres Bordeaux, France. He has made significant contributions to the field of magnetic materials, particularly through his innovative work on ferrofluids. His research focuses on the development of stable ferrofluids that can be utilized in various applications, including medical imaging.
Latest Patents
Mornet holds a patent for "Ferrofluids stable in neutral media and modified ferrofluids." This invention pertains to aqueous dispersions that consist of particles based on magnetic iron oxide with dimensions of ≤20 nm. The surface of these particles is modified by the grafting of aminated groups R, which bond covalently to the surface. The isoelectronic point of these modified particles is ≥10. The patent also describes methods for producing these aqueous suspensions and modifying the surface of the particles, particularly through the immobilization of polysaccharides like dextrans. This technology is particularly relevant for formulating magnetic compositions that can be administered in vivo, especially for injectable contrast agents used in MRI.
Career Highlights
Stéphane Mornet is affiliated with the Centre National de la Recherche Scientifique, a prestigious research institution in France. His work has garnered attention for its potential applications in medical technology and materials science. Mornet's innovative approach to ferrofluids has positioned him as a key figure in this specialized field.
Collaborations
Mornet has collaborated with esteemed colleagues such as Etienne Duguet and Joseph Portier. These partnerships have contributed to the advancement of research in ferrofluid technology and its applications.
Conclusion
Stéphane Mornet's contributions to the field of ferrofluids exemplify the intersection of innovation and practical application in science. His patented work not only advances our understanding of magnetic materials but also opens new avenues for medical applications.